GCO · Genesco Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $2.44B | $2.33B | $2.32B | $2.38B | $2.42B | $1.79B |
| Cost of Revenue | $1.31B | $1.23B | $1.23B | $1.25B | $1.24B | $982.06M |
| Gross Profit | $1.13B | $1.10B | $1.10B | $1.14B | $1.18B | $804.47M |
| R&D | - | - | - | - | - | - |
| SG&A | $1.10B | $1.08B | $1.08B | $1.04B | $1.03B | $813.77M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $53.33M | $52.46M | $49.44M | $42.82M | $42.97M | $46.50M |
| Operating Income | $17.31M | $13.93M | ($13.46M) | $93.24M | $155.57M | ($107.25M) |
| Interest Expense | - | - | $7.78M | $2.92M | $2.45M | $5.34M |
| Income Tax | ($685.0K) | $28.82M | $1.85M | $17.83M | $38.04M | ($55.64M) |
| Net Income | $13.27M | ($18.89M) | ($16.83M) | $71.92M | ($56.43M) | ($56.43M) |
| EPS - Basic | $1.28 | ($1.74) | ($1.50) | $5.77 | $8.11 | ($3.97) |
| EPS - Diluted | $1.25 | ($1.74) | ($1.50) | $5.66 | $7.92 | ($3.97) |
Balance Sheet
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $105.41M | $35.16M | $35.16M | $47.99M | $320.52M | $215.09M |
| Accounts Receivable | $39.83M | $48.87M | $53.62M | $40.82M | $39.51M | $31.41M |
| Inventory | $433.88M | $425.22M | $378.97M | $458.02M | $278.20M | $290.97M |
| Accounts Payable | $156.74M | $168.08M | $114.62M | $145.00M | $152.48M | $150.44M |
| Current Assets | $618.52M | $608.76M | $507.35M | $572.67M | $709.80M | $667.60M |
| Total Assets | $1.39B | $1.34B | $1.33B | $1.46B | $1.56B | $1.59B |
| Current Liabilities | $376.34M | $379.78M | $319.54M | $360.78M | $431.73M | $402.93M |
| Long-term Debt | $3.38M | $0 | $34.68M | $44.86M | $15.68M | $32.99M |
| Total Liabilities | $825.93M | $788.57M | $758.69M | $849.46M | $959.63M | $1.02B |
| Stockholders' Equity | $567.04M | $546.97M | $571.20M | $606.97M | $602.47M | $566.76M |
| Retained Earnings | $265.79M | $265.89M | $296.77M | $346.87M | $350.21M | $320.92M |
Cash Flow
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $145.76M | $87.89M | $94.80M | ($164.88M) | $239.87M | $157.74M |
| Investing Cash Flow | ($62.05M) | ($41.13M) | ($60.00M) | ($59.93M) | ($33.90M) | ($24.02M) |
| Financing Cash Flow | ($13.32M) | ($47.00M) | ($47.58M) | ($45.53M) | ($101.17M) | ($3.16M) |
| CapEx | $62.05M | $41.13M | $60.30M | $59.93M | $53.91M | $24.13M |
| Free Cash Flow | $83.71M | $46.75M | $34.49M | ($224.82M) | $185.97M | $133.61M |
Ratios
| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 46.3% | 47.2% | 47.3% | 47.6% | 48.8% | 45.0% |
| Operating margin | 0.7% | 0.6% | -0.6% | 3.9% | 6.4% | -6.0% |
| EBITDA margin | 2.9% | 2.9% | 1.5% | 5.7% | 8.2% | -3.4% |
| Net margin | 0.5% | -0.8% | -0.7% | 3.0% | -2.3% | -3.2% |
| Free cash flow margin | 3.4% | 2.0% | 1.5% | -9.4% | 7.7% | 7.5% |
| FCF / Net income | 6.31 | -2.48 | -2.05 | -3.13 | -3.30 | -2.37 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 45.2% | 46.4% | 46.5% | 43.7% | 42.7% | 45.6% |
| Effective tax rate | -5.4% | 290.2% | - | 19.9% | - | - |
| Return on assets | 1.0% | -1.4% | -1.3% | 4.9% | -3.6% | -3.6% |
| Return on equity | 2.3% | -3.5% | -2.9% | 11.8% | -9.4% | -10.0% |
| Return on invested capital | 3.0% | 1.3% | -1.8% | 11.5% | 19.9% | -14.1% |
| Liquidity | ||||||
| Current ratio | 1.64 | 1.60 | 1.59 | 1.59 | 1.64 | 1.66 |
| Quick ratio | 0.49 | 0.48 | 0.40 | 0.32 | 1.00 | 0.93 |
| Cash ratio | 0.28 | 0.09 | 0.11 | 0.13 | 0.74 | 0.53 |
| Leverage | ||||||
| Debt / Equity | 0.01 | 0.00 | 0.06 | 0.07 | 0.03 | 0.06 |
| Debt / Assets | 0.00 | 0.00 | 0.03 | 0.03 | 0.01 | 0.02 |
| Debt / EBITDA | 0.05 | 0.00 | 0.96 | 0.33 | 0.08 | - |
| Interest coverage | - | - | -1.7x | 31.9x | 63.5x | -20.1x |
| Equity multiplier | 2.46 | 2.44 | 2.33 | 2.40 | 2.59 | 2.80 |
| Liabilities / Assets | 0.59 | 0.59 | 0.57 | 0.58 | 0.61 | 0.64 |
| Efficiency | ||||||
| Asset turnover | 1.75 | 1.74 | 1.75 | 1.64 | 1.55 | 1.13 |
| Inventory turnover | 3.02 | 2.89 | 3.23 | 2.73 | 4.46 | 3.38 |
| Days sales outstanding | 6d | 8d | 8d | 6d | 6d | 6d |
| Days inventory outstanding | 121d | 126d | 113d | 134d | 82d | 108d |
| Days payable outstanding | 44d | 50d | 34d | 42d | 45d | 56d |
| Cash conversion cycle | 83d | 84d | 87d | 98d | 43d | 59d |
| Valuation | ||||||
| P / E | 23.1x | - | - | 8.5x | 8.1x | - |
| P / B | 0.5x | 0.8x | 0.5x | 1.0x | 1.5x | 1.0x |
| P / S | 0.1x | 0.2x | 0.1x | 0.3x | 0.4x | 0.3x |
| EV / EBITDA | 2.9x | 6.3x | 8.0x | 4.5x | 3.2x | - |
| Growth | ||||||
| Revenue growth (YoY) | 4.8% | 0.0% | -2.5% | -1.5% | 35.6% | -18.7% |
| Revenue CAGR (3y) | 0.7% | -1.4% | 9.2% | 2.8% | - | -5.7% |
| Revenue CAGR (5y) | 6.4% | 1.1% | - | 2.3% | - | - |
| Gross profit growth (YoY) | 2.7% | -0.2% | -3.3% | -3.8% | 46.8% | -24.3% |
| Operating income growth (YoY) | 24.3% | - | - | -40.1% | - | - |
| Net income growth (YoY) | - | -12.3% | - | - | 0.0% | - |
| EPS growth (YoY) | - | -16.0% | - | -28.5% | - | - |
| EPS CAGR (3y) | -39.6% | - | - | 13.0% | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 79.0% | 35.5% | - | - | 39.2% | 52.9% |
| FCF CAGR (5y) | -8.9% | -11.8% | - | - | 38.3% | 24.6% |
| Book value growth (YoY) | 3.7% | -4.2% | -5.9% | 0.7% | 6.3% | -8.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-01-31.
Business segments
$2.44B totalJourneys Group Segment$1.49B · 61.4%
Schuh Group Segment$500.02M · 20.5%
Johnston And Murphy Group Segment$320.20M · 13.1%
Genesco Brands Segment$121.23M · 5.0%
Stability scores
Altman Z′
FY 2026 · bankruptcy risk
2.36
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2026 · 9-point quality
7/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Retail-Shoe Stores
Comparing GENESCO INC against the 4 most active filers in the same SIC group.